Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease | Zendy

Tamara Isakova | Zendy; Huiliang Xie | Zendy; Wei Yang | Zendy; Dawei Xie | Zendy; Amanda H. Anderson | Zendy; Julia J. Scialla | Zendy; Patricia Wahl | Zendy; Orlando M. Gutiérrez | Zendy; Susan Steigerwalt | Zendy; Jiang He | Zendy; Stanley A. Schwartz | Zendy; Joan C. Lo | Zendy; Akinlolu Ojo | Zendy; James Sondheimer | Zendy; Chiyuan Hsu | Zendy; James P. Lash | Zendy; Mary B. Leonard | Zendy; John W. Kusek | Zendy; Harold I. Feldman | Zendy; Myles Wolf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

Author(s) -

Tamara Isakova,

Huiliang Xie,

Wei Yang,

Dawei Xie,

Amanda H. Anderson,

Julia J. Scialla,

Patricia Wahl,

Orlando M. Gutiérrez,

Susan Steigerwalt,

Jiang He,

Stanley A. Schwartz,

Joan C. Lo,

Akinlolu Ojo,

James Sondheimer,

Chiyuan Hsu,

James P. Lash,

Mary B. Leonard,

John W. Kusek,

Harold I. Feldman,

Myles Wolf

Publication year - 2011

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2011.826

Subject(s) - medicine , interquartile range , kidney disease , hazard ratio , fibroblast growth factor 23 , renal function , end stage renal disease , quartile , population , risk factor , prospective cohort study , proportional hazards model , confidence interval , gastroenterology , disease , parathyroid hormone , environmental health , calcium

A high level of the phosphate-regulating hormone fibroblast growth factor 23 (FGF-23) is associated with mortality in patients with end-stage renal disease, but little is known about its relationship with adverse outcomes in the much larger population of patients with earlier stages of chronic kidney disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research